Emil Bulatov
- Molecular Biology top 10%
- Oncology top 5%
- Immunology top 10%
- Genetics
- Biomedical Engineering
- Co-authors
- Alessio CiulliAlbert A. RizvanovEkaterina ZmievskayaAygul ValiullinaAlexey PetukhovIrina GaneevaRegina MiftakhovaAleksei Titov
- Topics
- CAR-T cell therapy research (20 papers)Virus-based gene therapy research (11 papers)Ubiquitin and proteasome pathways (10 papers)
- Cited by
- OncologyImmunologyMolecular Biology
- Journals
- Journal of Biological ChemistrySHILAP Revista de lepidopterologíaNano Letters
- Partner nations
- RussiaChinaUnited Kingdom
In The Last Decade
Emil Bulatov
54 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 102
- Molecular Biology 726
- Oncology 610
- Immunology 250
- Genetics 140
- Biomedical Engineering 133
Countries citing papers authored by Emil Bulatov
This map shows the geographic impact of Emil Bulatov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emil Bulatov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emil Bulatov more than expected).
Fields of papers citing papers by Emil Bulatov
This network shows the impact of papers produced by Emil Bulatov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emil Bulatov. The network helps show where Emil Bulatov may publish in the future.
Co-authorship network of co-authors of Emil Bulatov
This figure shows the co-authorship network connecting the top 25 collaborators of Emil Bulatov. A scholar is included among the top collaborators of Emil Bulatov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emil Bulatov. Emil Bulatov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 36 | |
| 4 | 20 | |
| 5 | 6 | |
| 6 | 2 | |
| 7 | 4 | |
| 8 | 3 | |
| 9 | 1 | |
| 10 | 6 | |
| 11 | 5 | |
| 12 | 1 | |
| 13 | 10 | |
| 14 | 43 | |
| 15 | 2 | |
| 16 | 30 | |
| 17 | 28 | |
| 18 | 1 | |
| 19 | 27 | |
| 20 | 21 |
About Emil Bulatov
Emil Bulatov is a scholar working on Oncology, Immunology and Molecular Biology, having authored 55 papers that have together received 1.2k indexed citations. Recurring topics across this work include CAR-T cell therapy research (20 papers), Virus-based gene therapy research (11 papers) and Ubiquitin and proteasome pathways (10 papers). The work is most often cited by research in Oncology (610 citations), Immunology (250 citations) and Molecular Biology (726 citations). Emil Bulatov has collaborated with scholars based in Russia, China and United Kingdom. Frequent co-authors include Alessio Ciulli, Albert A. Rizvanov, Ekaterina Zmievskaya, Aygul Valiullina, Alexey Petukhov, Irina Ganeeva, Regina Miftakhova, Aleksei Titov, Almaz A. Zagidullin and Nickolai A. Barlev. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Nano Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.